PT3139932T - Regime de tratamento para composto de tiacumicina - Google Patents

Regime de tratamento para composto de tiacumicina

Info

Publication number
PT3139932T
PT3139932T PT15731245T PT15731245T PT3139932T PT 3139932 T PT3139932 T PT 3139932T PT 15731245 T PT15731245 T PT 15731245T PT 15731245 T PT15731245 T PT 15731245T PT 3139932 T PT3139932 T PT 3139932T
Authority
PT
Portugal
Prior art keywords
treatment regimen
tiacumicin compound
tiacumicin
compound
regimen
Prior art date
Application number
PT15731245T
Other languages
English (en)
Inventor
Johannis Karas Andreas
Mark Longshaw Christopher
Original Assignee
Astellas Pharma Europe Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Europe Ltd filed Critical Astellas Pharma Europe Ltd
Publication of PT3139932T publication Critical patent/PT3139932T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
PT15731245T 2014-05-09 2015-05-11 Regime de tratamento para composto de tiacumicina PT3139932T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14075031 2014-05-09

Publications (1)

Publication Number Publication Date
PT3139932T true PT3139932T (pt) 2018-11-14

Family

ID=50771031

Family Applications (1)

Application Number Title Priority Date Filing Date
PT15731245T PT3139932T (pt) 2014-05-09 2015-05-11 Regime de tratamento para composto de tiacumicina

Country Status (23)

Country Link
US (1) US10137141B2 (pt)
EP (1) EP3139932B1 (pt)
JP (1) JP6579662B2 (pt)
KR (1) KR20160149288A (pt)
AU (1) AU2015258130B2 (pt)
CA (1) CA2948400A1 (pt)
CY (1) CY1120847T1 (pt)
DK (1) DK3139932T3 (pt)
EA (1) EA031756B1 (pt)
ES (1) ES2694028T3 (pt)
GE (1) GEP20186872B (pt)
HR (1) HRP20181756T1 (pt)
IL (1) IL248782B (pt)
LT (1) LT3139932T (pt)
MA (1) MA39952B1 (pt)
MD (1) MD4695C1 (pt)
PL (1) PL3139932T3 (pt)
PT (1) PT3139932T (pt)
RS (1) RS57994B1 (pt)
SI (1) SI3139932T1 (pt)
TR (1) TR201815891T4 (pt)
UA (1) UA122203C2 (pt)
WO (1) WO2015169451A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA034885B1 (ru) * 2015-07-03 2020-04-02 Астеллас Фарма Юэроп Лтд. Новая схема лечения тиакумициновым соединением

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918174A (en) 1986-09-26 1990-04-17 Abbott Laboratories Tiacumicin compounds
US5583115A (en) 1995-05-09 1996-12-10 Abbott Laboratories Dialkyltiacumicin compounds
US5767096A (en) 1996-07-12 1998-06-16 Abbott Laboratories Bromotiacumicin compounds
KR100972542B1 (ko) 2002-07-29 2010-07-28 옵티머 파마슈티칼즈, 인코포레이티드 티아쿠미신 제조법
US20070173462A1 (en) 2004-05-14 2007-07-26 Optimer Pharmaceuticals, Inc. Treatment of diseases associated with the use of antibiotics
BRPI0519890A2 (pt) 2005-01-31 2009-03-31 Optimer Pharmaceuticals Inc macrociclos de 18 elementos e seus análogos
US7378508B2 (en) 2007-01-22 2008-05-27 Optimer Pharmaceuticals, Inc. Polymorphic crystalline forms of tiacumicin B
US20080176927A1 (en) * 2007-01-19 2008-07-24 Optimer Pharmaceuticals, Inc. Compositions of stable tiacumicins
CN102030791B (zh) 2010-10-28 2013-01-23 中国科学院南海海洋研究所 四种台勾霉素类化合物及其制备方法和在制备抗菌药物中的应用
CN102115757B (zh) 2010-12-14 2015-10-28 中国科学院南海海洋研究所 台勾霉素的生物合成基因簇及其应用
WO2013138748A1 (en) * 2012-03-16 2013-09-19 Optimer Pharmaceuticals, Inc. Prevention of clostridium difficile infection in high risk patients
JO3464B1 (ar) * 2013-01-15 2020-07-05 Astellas Pharma Europe Ltd التركيبات الخاصة بمركبات التياكوميسين

Also Published As

Publication number Publication date
ES2694028T3 (es) 2018-12-17
LT3139932T (lt) 2018-11-12
UA122203C2 (uk) 2020-10-12
TR201815891T4 (tr) 2018-11-21
JP2017514880A (ja) 2017-06-08
IL248782A0 (en) 2017-01-31
MD4695B1 (ro) 2020-05-31
GEP20186872B (en) 2018-06-25
HRP20181756T1 (hr) 2018-12-28
MD4695C1 (ro) 2021-02-28
AU2015258130A1 (en) 2016-12-15
KR20160149288A (ko) 2016-12-27
EP3139932A1 (en) 2017-03-15
IL248782B (en) 2020-08-31
US20170143750A1 (en) 2017-05-25
CA2948400A1 (en) 2015-11-12
MD20160131A2 (ro) 2017-05-31
MA39952A (fr) 2017-03-15
EA031756B1 (ru) 2019-02-28
EA201692107A1 (ru) 2017-04-28
US10137141B2 (en) 2018-11-27
PL3139932T3 (pl) 2019-02-28
MA39952B1 (fr) 2018-12-31
CY1120847T1 (el) 2019-12-11
SI3139932T1 (sl) 2018-12-31
EP3139932B1 (en) 2018-08-01
RS57994B1 (sr) 2019-01-31
WO2015169451A1 (en) 2015-11-12
DK3139932T3 (en) 2018-11-12
JP6579662B2 (ja) 2019-09-25
AU2015258130B2 (en) 2019-10-31

Similar Documents

Publication Publication Date Title
AP2017009836A0 (en) Aminopyridyloxypyrazole compounds
GB201415573D0 (en) Compounds
GB201411418D0 (en) Compounds
GB201418300D0 (en) Compounds
GB201410430D0 (en) Compounds
GB201402431D0 (en) Compounds
GB201417369D0 (en) Compounds
GB201416186D0 (en) Compounds
GB201417561D0 (en) Compounds
GB201404987D0 (en) Compounds
GB201406956D0 (en) Compounds
GB201406591D0 (en) Compounds
GB201419228D0 (en) Compounds
AP2017009778A0 (en) Azetidinyloxyphenylpyrrolidine compounds
GB201419264D0 (en) Compounds
GB201412660D0 (en) Compounds
GB201417168D0 (en) Compounds
GB201419015D0 (en) Compounds
HRP20181756T1 (hr) Režim liječenja sa spojem tiakumicina
GB201407695D0 (en) Compounds
GB201405361D0 (en) Compounds
GB201416462D0 (en) Compound for use
GB201419321D0 (en) Compounds
GB201419322D0 (en) Compounds
GB201418491D0 (en) Compounds